JyotsnaFuloriaMD

Oncology • New Orleans, LA

Gastrointestinal Cancer, Hematologic Oncology

Director, Clinical Oncology Research Ochsner

Join to view full profile

Dr. Fuloria is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fuloria's full profile

Already have an account?

Office
2000 Canal St
New Orleans, LA 70112
Phone+1 504-702-4410

Fax+1 504-702-2118
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1995 - 1997
Presence Saint Francis HospitalFellowship, Hematology, 1994 - 1997
Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1991 - 1994
Maulana Azad Medical CollegeClass of 1989

Certifications & Licensure

LA State Medical License 2001 - 2024
IL State Medical License 1994 - 1999

Awards, Honors, & Recognition

Listed Best Doctors America Physicians
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Acute Pain Caused by Paclitaxel in Patients With Cancer Start of enrollment: 2009 Feb 01
Completed
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Home-Based Programs for Improving Sleep in Cancer Survivors Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy Start of enrollment: 2011 Apr 01
Completed
Phase 3
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15
Completed
Phase 2
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients w...
Michael T Eadon, Kerri L Cavanaugh, Lori A Orlando, David Christian, Hrishikesh Chakraborty, Kady-Ann Steen-Burrell, Peter Merrill, Janet Seo, Diane Hauser, Rajbir Sin...> ;Contemporary Clinical Trials. 2022 Aug 1
2 citations
Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19.
Aditi Kuchi, Jiande Wu, Jyotsna Fuloria, Chindo Hicks> ;International Journal of Environmental Research and Public Health. 2022 Mar 15
4 citations
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control ...
Steven M Smith, Raj A Desai, Marta G Walsh, Ester Kim Nilles, Katie Shaw, Myra Smith, Alanna M Chamberlain, Catherine G Derington, Adam P Bress, Cynthia H Chuang, Dani...> ;American Heart Journal Plus. 2022 Jan 1
1 citations
Association Between the 5As and Stage of Change Among African American Smokers Eligible for Low-Dose Computed Tomography Screening
Yu-Hsiang Kao, Tung-Sung Tseng, Michael D. Celestin, Jennifer Hart, Lucretia Young, Leonard R. Bok, David L. Smith, Jyotsna Fuloria, Sarah Moody-Thomas, Edward J. Trap...> ;Preventing Chronic Disease. 2021 Jul 15
9 citations
Increasing Readiness for Early Integrated Palliative Oncology Care: Development and Initial Evaluation of the EMPOWER 2 Intervention.
Laura M. Perry, Oliver Sartor, Sonia Malhotra, Sarah Alonzi, Seowoo Kim, Hallie M. Voss, James Rogers, William Robinson, Kendra Harris, Jessica Shank, David G. Morriso...> ;Journal of Pain and Symptom Management. 2021 Apr 20
10 citations
Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19.
Joseph A. Lasky, Jyotsna Fuloria, Marion E. Morrison, Randall Lanier, Odin Naderer, Tom Brundage, Allen Melemed> ;Advances in Therapy. 2021 Jan 1
5 citations
Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans-a mixed method study.
Tung-Sung Tseng, Tyra Gross, Michael D Celestin, Wendy Dang, Lucretia Young, Yu-Hsiang Kao, David L Smith, Leonard R Bok, Jyotsna Fuloria, Sarah Moody-Thomas, Mirandy Li> ;Translational Cancer Research. 2019 Jul 1
6 citations
Gallbladder Neuroendocrine Neoplasms: A Case Report of Gallbladder Small Cell Carcinoma
Dalal Nemenqani, Jyotsna Fuloria, Rehab A. Karam, Haneen Hammadi> ;Journal of Gastrointestinal Cancer. 2016 Dec 1
21 citations
Novel therapeutic agents in the treatment of metastatic colorectal cancer.
Sachin Gopalkrishna Pai, Jyotsna Fuloria> ;World Journal of Gastrointestinal Oncology. 2016 Jan 15
5 citations
Rituximab-Induced Acute ST Elevation Myocardial Infarction
Amit N. Keswani, Cody Williams, Jyotsna Fuloria, Nichole M. Polin, Eiman Jahangir> ;Ochsner Journal. 2015 Jun 20
13 citations
Phase III double‐blind, placebo‐controlled study of gabapentin for the prevention of delayed chemotherapy‐induced nausea and vomiting in patients receiving highly emet...
Debra L. Barton, Gita Thanarajasingam, Jeff A. Sloan, Brent Diekmann, Jyotsna Fuloria, Lisa A. Kottschade, Alan P. Lyss, Anthony J. Jaslowski, Miroslaw Mazurczak, Scot...> ;Cancer. 2014 Nov 15
7 citations
Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer.
Jyotsna Fuloria> ;Oncotargets and Therapy. 2012 Aug 17
15 citations
Hepatic Arterial Infusion and Systemic Chemotherapy after Multiple Metastasectomy in Patients with Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer...
John S. Bolton, Michael J. O'Connell, Michelle R. Mahoney, Gist H. Farr, Tom R. Fitch, William J. Maples, David M. Nagorney, Joseph Rubin, Jyotsna Fuloria, Preston D. ...> ;Clinical Colorectal Cancer. 2012 Mar 1
16 citations
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8
Ann E. Kearns, Donald W. Northfelt, Amylou C. Dueck, Pamela J. Atherton, Shaker R. Dakhil, Kendrith M. Rowland, Jyotsna Fuloria, Patrick J. Flynn, Todor Dentchev, Char...> ;Supportive Care in Cancer. 2010 Mar 1
34 citations
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
Mark D. Pegram, Virginia F. Borges, Nuhad K. Ibrahim, Jyotsna Fuloria, Charles L. Shapiro, Susan Perez, Karen Wang, Franziska Schaedli Stark, Nigel Courtenay Luck> ;Breast Cancer Research. 2009 Oct 7
32 citations
Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin’s...
David I. Quinn, John Nemunaitis, Jyotsna Fuloria, Carolyn D. Britten, Nashat Gabrail, Lorrin Yee, Milin Acharya, Kai Chan, Nadine Cohen, Assen Dudov> ;Clinical Pharmacokinetics. 2009 Jan 1
Phase I pharmacokinetics (PK) of humanized anti-MUC-1 antibody R1550.
Pegram MD, Borges V, Fuloria J, Ibrahim N, Shapiro CL, Perez ES, Wang K, Schaedeli Stark F, Yeon C, Courtenay-Luck N> ;J. Clin. Oncol.. 2006-06-20
1 citations
The role of chemotherapy in colon cancer.
Ana Maria Gonzalez-Angulo, Jyotsna Fuloria> ;Ochsner Journal. 2002 Jan 1
8 citations
Cyclooxygenase 2 Inhibitors and Colon Cancer
Ana Maria Gonzalez-Angulo, Jyotsna Fuloria, Om Prakash> ;Ochsner Journal. 2002 Jan 1
98 citations
A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
D C Doval, J S Sekhon, Saroj Gupta, J Fuloria, Vijay K. Shukla, S Gupta, B.S. Awasthy> ;British Journal of Cancer. 2004 Apr 13
23 citations
A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma.
Purvish M. Parikh, J Fuloria, G Babu, D C Doval, B S Awasthy, V R Pai, P S Prabhakaran, Al B. Benson> ;Tropical Gastroenterology. 2005 Jul 1
5 citations
A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer.
S.K. Gupta, S. John, R. Naik, R. Arora, B. Selvamani, J Fuloria, N. Ganesh, B.S. Awasthy> ;Gynecologic Oncology. 2005 Jul 1
Join now to see all

Grant Support

NCORP OchsnerNational Cancer Institute (NCI)2014–Present
Ochsner Community Clinical Oncology ProgramNational Cancer Institute2008–2011

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

University Medical CenterNew Orleans, Louisiana